Navigation Links
MarketsandMarkets Partners With IIR USA for Their Event 'Advanced Biomarker Strategies in Oncology Drug Development'
Date:2/1/2010

DALLAS, February 1 /PRNewswire/ -- The organizers of the Annual Partnerships in Clinical Trials and Central Labs events present Advanced Biomarker Strategies in Oncology Drug Development. The conference is organized at the Grand Hyatt, San Francisco from February 4-5, 2010. This event is FREE for executives from the biotech and pharmaceutical industries.

This two-day program focuses exclusively on the latest developments in oncology biomarkers. It provides an opportunity to interact with the leaders in clinical R&D, oncology, drug development, and translational research. The program aims to deliver and develop solutions, industry standards, and practical applications for biomarker development and validation. This unique program is the first of our three part Target Clinical Trials Series, delivering therapeutic-specific strategies to facilitate execution of successful clinical trials.

For more information on this event, please visit http://www.iirusa.com/targetbiomarkers.

For more information on the Target Clinical Trial Series, visit http://www.clinicaltrialseries.com.

About MarketsandMarkets

MarketsandMarkets is a research and consulting firm that publishes 120 market research reports per year. Each strategically analyzed report contains 250 pages of valuable market data, including more than 100 market data summary tables and in-depth, five-level segmentation for each of the products, services, applications, technologies, ingredients and stakeholders categories. Our reports also analyze about 200 patents, over 50 companies and micro markets that are mutually exclusive and collectively exhaustive. Browse all our 120 titles at http://www.marketsandmarkets.com.

The Global Biomarker Market report published by MarketsandMarkets analyzes the global biomarker tools and services markets over the period 2009-2014. The report studies the major market drivers, restraints, and opportunities for the global biomarker market; and evaluates the major trends in the macro- and micro-markets with respect to different geographic regions.

The global biomarker market is estimated to be $20.5 billion by 2014, growing at a CAGR of 19.7 % from 2009 to 2014. Market growth is driven mainly by the high demand for biomarkers in the field of drug discovery; from the increasing demand from the baby boomer generation in the U.S.; and from Asia's emerging IT industry. Biomarker applications are increasing in cancer diagnosis as novel tools are being developed to increase the discovery speed of cancer biomarkers.

SCOPE AND FORMAT

The report analyzes the global biomarker market into the following segments:

    - Tools Market-(pregenomic biomarkers and technologies, post
      genomic biomarkers and technologies, imaging biomarkers, and others)

    - Services Market-(pre- and post-clinical biomarker services,
      sample preparation, mirna analysis, and others)

    - Application Market-(diagnosis, and drug development and discovery)


    Contact
    Ms. Sunita
    7557 Rambler Road,
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004
    Email: sales@marketsandmarkets.com

SOURCE MarketsandMarkets


'/>"/>
SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MarketsandMarkets Partners with the 9th Annual ePharma Summit to be Held on February 8 -10, 2010
2. MarketsandMarkets: Global Probiotics Market Worth US$32.6 Billion by 2014
3. MarketsandMarkets: Healthcare Information Technology Systems Market to be Worth $53.8 Billion by 2014
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
8. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
9. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
10. UNICEF Partners With Causes on Facebook to Launch Charity Gift Feature
11. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... Lilly and Company (NYSE: LLY ) will ... 2017 on Tuesday, October 24, 2017. Lilly will also ... investment community and media to further detail the company,s ... at 9 a.m. Eastern time. Investors, media and the ... conference call through a link that will be posted ...
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile app ... struggle to reverse the tide of prescription drug addiction. The ... their medicine intake and stepping down their dosage in a ... launch in December 2017; the first 100,000 people to sign ... at http://www.rebound-solution.com/ ...
(Date:9/27/2017)... 27, 2017  Commended for their devotion to personalized service, ... as number one in the South Florida Business Journal,s 50 ... 5000 yearly list, the national specialty pharmacy has found its ... will soon be honored by SFBJ as the 2017 ... Set to receive his award in October, Bardisa said ...
Breaking Medicine Technology:
(Date:10/13/2017)... , ... October 13, 2017 , ... PurhealthRX , ... Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize ... providing a CBD form that can be easily incorporated into liquid products, while reducing ...
(Date:10/13/2017)... OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... or dementia. However, many long-term care insurance companies have a waiver for care if ... the 90-day elimination period, when the family pays for care, is often waived, so ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the ... published author, William Nowers. Captain Nowers and his wife, Millie, have six children, ... in the Navy. Following his career as a naval aviator and carrier pilot, ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
Breaking Medicine News(10 mins):